You are here: Industry Insights > COVID-19

News List

KU Leuven vaccine candidate protects against COVID-19 and yellow fever worldpharmanews
December 04, 2020
Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a result also works against yellow fever.
FDA grants Fast Track designation to COVID-19 ARDS treatment europeanpharmaceuticalreview
December 04, 2020
The designation should expedite the review of remestemcel-L, a cellular therapy that has shown promise in treating acute respiratory distress syndrome (ARDS) in COVID-19 patients.
RedHill to Continue Phase 2/3 COVID-19 Study with Opaganib americanpharmaceuticalreview
December 04, 2020
RedHill Biopharma announced that the global Phase 2/3 study with opaganib (Yeliva?, ABC294640) in patients hospitalized with severe COVID-19 pneumonia has received a unanimous recommendation to continue, following a pre-scheduled safety review by an ...
Senhwa Enrolls First Patient in Silmitasertib Trial for COVID-19 americanpharmaceuticalreview
December 04, 2020
Senhwa Biosciences announced the first patient was enrolled into a Phase II investigator-initiated trial (IIT) of its anti-SARS-CoV-2 investigational drug, Silmitasertib, as a treatment for coronavirus disease (COVID-19) at the ...
FDA approves Rhizen Pharmaceuticals’ application to study Covid-19 drug pharmaceutical-technology
December 04, 2020
The US Food and Drug Administration (FDA) has approved Rhizen Pharmaceuticals’ Investigational New Drug (IND) application to study its dihydroorotate dehydrogenase (DHOHD) inhibitor, RP7214, for SARS-CoV-2 infection.
US buys additional 650,000 doses of Lilly’s Covid-19 antibody for $812.5m pharmaceutical-technology
December 04, 2020
The US government has entered into a purchase agreement worth $812.5m to procure 650,000 additional doses of Eli Lilly and Company’s neutralising antibody bamlanivimab (LY-CoV555) 700mg.
NPPA extends revised ceiling price of Heparin Injection till March 2021 expresspharma
December 04, 2020
This year in June, the NPPA had allowed 50 per cent increase in the price of heparin injection in the country which was valid until December 31, 2020.
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe prnasia
December 03, 2020
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. said Thursday that the extraction-free application of Allplex? SARS-CoV-2/FluA/FluB/RSV Assay is now available in Europe.
Pharmacists Ready to Receive and Administer COVID-19 Vaccines, According to APhA Survey prnewswire
December 03, 2020
More than three quarters of pharmacists plan to be vaccinated with one of the COVID vaccines, and 60% will be set up and ready to vaccinate patients as soon as the vaccine is available, in a recent nationwide survey of 400 pharmacists conducted by the ...
Apex Innovative Sciences Pioneers Continuity Strategy in Clinical Site Services During COVID-19 prnewswire
December 03, 2020
Since the emergence of the COVID-19 global pandemic, Apex Innovative Sciences (Apex) has distinguished itself as a leader in clinical trial continuity strategies.